InvestorsHub Logo
Followers 195
Posts 11275
Boards Moderated 0
Alias Born 11/29/2007

Re: None

Tuesday, 08/23/2016 9:04:14 AM

Tuesday, August 23, 2016 9:04:14 AM

Post# of 15662
"Ampligen is an experimental therapeutic in a new class of specifically-configured RNA compounds for the treatment of diseases with immunologic defects and/or viral causation. It's been 'experimental' for 25 years so investors should rely on thorough due diligence here."

- Seeking Alpha